Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Whoop opens blood-testing service to what it says is a 350,000-person waitlist

From TechCrunch

By Julie Bort

September 30, 2025

Whoop opens blood-testing service to what it says is a 350,000-person waitlist

Whoop opens blood-testing service to what it says is a 350,000-person waitlist

Fitness band maker Whoop formally opened Whoop Advanced Labs for business on Tuesday. Some 350,000 people were on the waitlist after the service was previewed in May, the company told TechCrunch.

Whoop Advanced Labs offers health-screening blood tests from Quest Diagnostics that cover a variety of markers, from calcium to white blood cells. The platform integrates those results with the band’s continuous monitoring of activity, sleep, respiratory rate, and blood pressure to offer more personalized wellness advice.

Advanced Labs costs $199 for one annual test, $349 for two, or $599 for four per year. The Whoop device itself is also a membership ranging from $200 to $350 annually, depending on the wearable strap’s features.

Whoop joins a growing number of startups offering wellness through lower-cost, out-of-pocket blood screenings on a subscription basis. Others include Dr. Mark Hyman’s Function Health, which costs $500 a year for tests at three-month intervals, plus optional body imaging, and Fountain Life, the longevity startup from Tony Robbins and Peter Diamandis, which costs more than $20,000 a year.

View original article on techcrunch.com

Most Recent

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Sheryl Sandberg leads $10 million investment in AI-powered vehicle inspection service

Sheryl Sandberg leads $10 million investment in AI-powered vehicle inspection service

The startup, founded in 2021, lets enterprise customers use smartphones to scan and spot vehicle damage.

Jul 16, 2026

Similar Posts

Fitness tracker Whoop faces unhappy customers over upgrade policy

Fitness tracker Whoop faces unhappy customers over upgrade policy

Whoop has backed down, somewhat, from the controversial upgrade plans around its Whoop 5.0 fitness tracker. When the company first announced Whoop 5.0

May 11, 2025

Emm raises $9M seed to create one of the world’s first ‘smart’ menstrual cups

Emm raises $9M seed to create one of the world’s first ‘smart’ menstrual cups

The product functions like a regular menstrual cup — designed to store period blood rather than absorb it. Emm’s medical-grade silicone is “fitted with ultra-thin, advanced sensor technology" that gathers data that will help users understand patterns about their cycles.

Nov 18, 2025

Whoop’s valuation just tripled to $10 billion

Whoop’s valuation just tripled to $10 billion

The fitness tracking startup just closed a $575 million Series G with Cristiano Ronaldo and LeBron James among its investors. The obvious question looming over a round of this size at this valuation: Is an IPO coming?

Mar 31, 2026

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

India-based Miraqules developed a nanotechnology that mimics blood clotting proteins to quickly stop heavy bleeding.

Oct 27, 2025

Most Recent

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Sheryl Sandberg leads $10 million investment in AI-powered vehicle inspection service

Sheryl Sandberg leads $10 million investment in AI-powered vehicle inspection service

The startup, founded in 2021, lets enterprise customers use smartphones to scan and spot vehicle damage.

Jul 16, 2026

Similar Posts

Fitness tracker Whoop faces unhappy customers over upgrade policy

Fitness tracker Whoop faces unhappy customers over upgrade policy

Whoop has backed down, somewhat, from the controversial upgrade plans around its Whoop 5.0 fitness tracker. When the company first announced Whoop 5.0

May 11, 2025

Emm raises $9M seed to create one of the world’s first ‘smart’ menstrual cups

Emm raises $9M seed to create one of the world’s first ‘smart’ menstrual cups

The product functions like a regular menstrual cup — designed to store period blood rather than absorb it. Emm’s medical-grade silicone is “fitted with ultra-thin, advanced sensor technology" that gathers data that will help users understand patterns about their cycles.

Nov 18, 2025

Whoop’s valuation just tripled to $10 billion

Whoop’s valuation just tripled to $10 billion

The fitness tracking startup just closed a $575 million Series G with Cristiano Ronaldo and LeBron James among its investors. The obvious question looming over a round of this size at this valuation: Is an IPO coming?

Mar 31, 2026

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

India-based Miraqules developed a nanotechnology that mimics blood clotting proteins to quickly stop heavy bleeding.

Oct 27, 2025